Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03177291
Title Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Pemetrexed Disodium + Pirfenidone

Carboplatin + Paclitaxel + Pirfenidone

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.